Navigating Due Diligence in Cell and Gene Therapy: Key Risks and Strategic Insights
The Cell and gene Therapy (CGT) industry is experiencing rapid growth. It offers groundbreaking treatments that have the potential to improve patient outcomes across a range of diseases significantly. Unlike traditional pharmaceuticals, CGT products leverage genetic modification, cell reprogramming, and regenerative medicine to target the root causes of diseases rather than just managing symptoms. As a result, […]
